Physician profile
Brandy Cross
NPI 1831396225
$4,834.85
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,432 · 2020: $2,592 · 2022: $111 · 2023: $553 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Orthopedics LLC | $2,136.00 | 2019-2020 | |
| Axogen | $1,724.89 | 2020-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Skeletal Dynamics INC | $402.08 | 2019-2023 | Implate, Geminus, Align |
| Trice Medical, INC. | $243.35 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $154.85 | 2019-2023 | Xiaflex |
| Anika Therapeutics, INC. | $94.48 | 2023 | Tactoset |
| Solventum Corporation | $18.33 | 2024 | Prevena, Activ.A.C. |
| Integra Lifesciences Corporation | $15.76 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Checkpoint Surgical, INC | $15.62 | 2023 | Checkpoint Stimulators |
| Sonex Health, INC. | $15.33 | 2024 | Sx-One Microknife |
| Stryker Corporation | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.